These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 3925753)
1. The evaluation of factor VIII antigen by means of a simple slide test. Casonato A; Fabris F; Vicariotto M; Girolami A Am J Clin Pathol; 1985 Jul; 84(1):107-11. PubMed ID: 3925753 [TBL] [Abstract][Full Text] [Related]
2. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results]. Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207 [TBL] [Abstract][Full Text] [Related]
3. A critical evaluation of the available methods for the determination of factor VIII von Willebrand. Casonato A; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):670-84. PubMed ID: 2435633 [TBL] [Abstract][Full Text] [Related]
4. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease. Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054 [TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases. Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911 [TBL] [Abstract][Full Text] [Related]
6. Conformational changes in von Willebrand's factor protein: effects on the binding of factor VIII-coagulant. Benson RE; Jones DW; Dodds WJ Am J Hematol; 1986 Jun; 22(2):113-22. PubMed ID: 3085479 [TBL] [Abstract][Full Text] [Related]
7. Von Willebrand's syndrome. Studies on a variant factor VIII. Hill FG; Chan MC; Hardisty RM Haemostasis; 1976; 5(5):276-84. PubMed ID: 797643 [TBL] [Abstract][Full Text] [Related]
8. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [TBL] [Abstract][Full Text] [Related]
9. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease. Chediak J; Peake I; Bloom A Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844 [TBL] [Abstract][Full Text] [Related]
10. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Aihara M; Kimura A; Chiba Y; Yoshida Y Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084 [TBL] [Abstract][Full Text] [Related]
11. Factor VIII complex in myelomatosis and related disorders. Leone G; Valori VM; Zini G; Bavaro P; Bartoloni C; Bizzi B Ric Clin Lab; 1982; 12(4):581-8. PubMed ID: 6818670 [TBL] [Abstract][Full Text] [Related]
12. Effect of insulin treatment in streptozocin-induced diabetic rats on in vitro platelet function and plasma von Willebrand factor activity and factor VIII-related antigen. Winocour PD; Lopes-Virella M; Laimins M; Colwell JA J Lab Clin Med; 1985 Sep; 106(3):319-25. PubMed ID: 3928783 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease. Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757 [TBL] [Abstract][Full Text] [Related]
14. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content. Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944 [TBL] [Abstract][Full Text] [Related]
15. Use of a simple visual assay of Willebrand factor for diagnosis and carrier identification. Reisner HM; Katz HJ; Goldin LR; Barrow ES; Graham JB Br J Haematol; 1978 Oct; 40(2):339-50. PubMed ID: 309339 [TBL] [Abstract][Full Text] [Related]
16. Factor VIII (procoagulant activity VIII:C, and antigen VIII:CAg, related antigen VIIIR:Ag and ristocetin cofactor VIIIR:Cof) in intensive care patients with clinically suspected disseminated intravascular coagulation (DIC). Tran TH; Lämmle B; Duckert F Am J Clin Pathol; 1984 Nov; 82(5):565-72. PubMed ID: 6437209 [TBL] [Abstract][Full Text] [Related]
17. Measurement of canine von Willebrand factor using ristocetin and Polybrene. Diagnosis of canine von Willebrand's disease. Rosborough TK; Johnson GS; Benson RE; Swaim WR; Dodds WJ J Lab Clin Med; 1980 Jul; 96(1):47-56. PubMed ID: 6967101 [TBL] [Abstract][Full Text] [Related]
18. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442 [TBL] [Abstract][Full Text] [Related]
19. VIIIR; Ag in platelets from patients with various forms of von Willebrand's disease. Holmbeg L; Nilsson IM Thromb Haemost; 1979 Oct; 42(3):1033-8. PubMed ID: 388718 [TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease. Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]